Open AccessAntibody-Based Treatment Approaches in Multiple Myeloma
Author(s) -
Hitomi Hosoya,
Surbhi Sidana
Publication year - 2021
Publication title -
current hematologic malignancy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.299
H-Index - 35
eISSN - 1558-822X
pISSN - 1558-8211
DOI - 10.1007/s11899-021-00624-6
Subject(s) - daratumumab , medicine , multiple myeloma , monoclonal antibody , antibody , clinical trial , antibody drug conjugate , bispecific antibody , oncology , immunology
The field of multiple myeloma treatment has entered a new era with antibody-based approaches in clinical practice. In this review, we focus on the clinical approaches of utilizing antibody-based modality, specifically monoclonal antibodies, antibody-drug conjugates, and bispecific T-cell antibodies in the treatment of multiple myeloma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom